PLYMOUTH MEETING, PA—Should antibiotic bone cement products be used in place of standard bone cement products to prevent infection after standard total hip or knee replacement surgery? That’s a question that the experts at ECRI Institute have been fielding a lot lately.

While there isn’t a simple answer, ECRI Institute, an independent nonprofit dedicated to researching the best approaches to patient care, will tackle issues and evidence surrounding bone cement—both antibiotic-laced and standard cements—in its February 18 educational webinar, "Antibiotic Bone Cement: Fighting Infection or Fighting Your Bottom Line?"

Subject matter experts from ECRI Institute’s health technology assessment and supply price benchmarking services will review today’s most popular antibiotic-laced and standard bone cements, and provide guidance for selecting products based on the best available clinical evidence and pricing data for the appropriate joint replacement procedure. Specifically, the webinar will examine the following:

  • Clinical evidence for the role of antibiotic bone cement in preventing deep infection
  • Current methods to reduce risk of infection
  • Commercially available antibiotic bone cement products and how they compare to standard products
  • Market share of antibiotic cements
  • Prices paid by hospitals based on ECRI Institute data

The webinar is designed to help value analysis committees with orthopedic and spine product oversight, clinical trauma teams, surgeons, and supply chain professionals make more informed decisions on bone cement products based on cost and clinical evidence.

“Our independent, unbiased research will help hospitals get a clearer picture of whether antibiotic bone cement products really do a better job at preventing infection than standard products, and when they should and should not be used. Appropriate evidence-based utilization can help hospitals save money,” says Diane Robertson, director, health technology assessment information service, ECRI Institute.

“From a pricing perspective, we’ll offer a glimpse into the current market share of antibiotic and standard bone cement products, and take a look at the lowest, average, and highest prices paid so hospitals will have a starting point for investigating opportunities for savings,” says Timothy Browne, director, PriceGuide advisory service, ECRI Institute.

The webinar will provide attendees with ample time to interact with the panel during the Q&A session and also encourages participation.

This live activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). ECRI Institute is accredited by the ACCME to provide continuing medical education for physicians.

ECRI Institute designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 1.5 California State Nursing contact hours by the provider, Debora Simmons, who is approved by the California Board of Registered Nursing, Provider Number CEP 13677.

To learn more or to register, visit or contact ECRI Institute by e-mail at; by telephone at (610) 825-6000, ext. 5889; by fax at (610) 834-0240; or by mail at 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, USA. ECRI’s European office can be contacted at; ECRI’s Malaysian office can be contacted at; and ECRI’s Middle Eastern office can be contacted at ECRI also offers free resources in our online eNewsletters.


Social Sharing

  • Feb. 18 webinar by @ECRI_Institute will cover evidence, cost of antibiotic and standard bone cement #HTA #bonecement
  • ECRI Institute's 2/18 webinar to dissect evidence and pricing of antibiotic and standard bone cements #HTA #bonecement

About ECRI Institute
ECRI Institute (, a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes enable improved patient care. As pioneers in this science for nearly 50 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. Strict conflict-of-interest guidelines ensure objectivity. ECRI Institute is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO is listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. Find ECRI Institute on Facebook ( and on Twitter (

For More Information Contact:
Laurie Menyo, Director of Public Relations and Marketing Communications
(610) 825-6000, ext. 5310